Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis

Abstract excerpt

The lack of vaccine and limited antiviral options against respiratory syncytial virus (RSV) highlights the need for novel therapeutic strategies. One alternative is to develop drugs that target host factors required for viral replication. Several microarray and proteomics studies had been published to identify possible host factors that are affected during RSV replication. In order to obtain a comprehensive...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Respiratory viral infections research
• Share to RNA modifications and cancer